The purpose of this study is to evaluate the safety and efficacy of zipalertinib inpatients with locally advanced or metastatic NSCLC harboring EGFR ex20ins mutations andother mutations.
The purpose of this study is to evaluate the safety and efficacy of zipalertinib inpatients with locally advanced or metastatic NSCLC harboring EGFR ex20ins mutations andother mutations.
